Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Isis Polianna Silva Ferreira de Carvalho"'
Autor:
Joslaine Nunes Aguiar, Isis Polianna Silva Ferreira de Carvalho, Raissa Allan Santos Domingues, Marta da Cunha Lobo Souto Maior, Vera Lucia Luiza, Jorge Otávio Maia Barreto, Noemia Urruth Leão Tavares
Publikováno v:
Revista Panamericana de Salud Pública, Vol 47, Iss 77, Pp 1-13 (2023)
Objetivo. Mapear políticas relacionadas à prevenção e ao controle da resistência aos antimicrobianos na perspectiva da saúde humana no Brasil e sistematizar a evolução histórica dessas políticas. Método. Desenvolveu-se uma revisão de esco
Externí odkaz:
https://doaj.org/article/12160eb80c8f4ef7b0102c452df41eb6
Autor:
Fatima Sonally Sousa Gondim, Lucia Rolim Santana de Freitas, Isis Polianna Silva Ferreira de Carvalho, Cynthia Braga
Publikováno v:
Epidemiologia e Serviços de Saúde, Vol 31, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/c0ae088e305144b3a2d2c891bd9d8307
Autor:
Joslaine de Oliveira Nunes, Raissa Allan Santos Domingues, Roberto Mauro Pinto Coelho Barcellos, Bárbara Manuella Cardoso Sodré Alves, Isis Polianna Silva Ferreira de Carvalho, Noemia Urruth Leão Tavares
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0263305 (2022)
IntroductionAntimicrobial resistance (AMR) is considered one of the biggest health challenges of the 21st century. It has both social and economic consequences; therefore, timely review of public health policies that have been designed to manage AMR
Externí odkaz:
https://doaj.org/article/544e4f03a3b44a5f857765133b5d83b7
Autor:
Fatima Sonally Sousa, Gondim, Lucia Rolim Santana de, Freitas, Isis Polianna Silva Ferreira de, Carvalho, Cynthia, Braga
Publikováno v:
Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil. 31(1)
Autor:
Henry Maia Peixoto, Gustavo Adolfo Sierra Romero, Maria Regina Fernandes de Oliveira, Isis Polianna Silva Ferreira de Carvalho
Publikováno v:
Value in Health Regional Issues. 23:77-84
Objectives To estimate the budget impact of the expansion of liposomal amphotericin B use for all confirmed cases of visceral leishmaniasis (VL) in Brazil. Currently, the first-line medicine for VL treatment is meglumine antimoniate. Liposomal amphot
Autor:
Henry Maia Peixoto, Gustavo Adolfo Sierra Romero, Maria Regina Fernandes de Oliveira, Isis Polianna Silva Ferreira de Carvalho
Publikováno v:
Tropical Medicine & International Health. 24:1064-1077
To estimate the cost-effectiveness of strategies for the treatment of VL in Brazil.Cost-effectiveness study comparing three therapeutic options: meglumine antimoniate (MA), liposomal amphotericin B (LAMB) and a combination of LAMB plus MA (LAMB plus
Autor:
Isis Polianna Silva Ferreira de Carvalho, Gustavo Adolfo Sierra Romero, Henry Maia Peixoto, Maria Regina Fernandes de Oliveira
Publikováno v:
Tropical medicineinternational health : TMIH. 22(12)
Objective To estimate the Brazilian direct and indirect costs of human visceral leishmaniasis (VL) in 2014. Methods Cost-of-illness study on the Brazilian public health system and societal perspective. VL cases registered in the Notifiable Diseases I
Publikováno v:
Value in Health. 20:A929